X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (294) 294
Trade Publication Article (40) 40
Publication (38) 38
Magazine Article (33) 33
Newspaper Article (13) 13
Book Review (4) 4
Web Resource (4) 4
Book / eBook (2) 2
Book Chapter (2) 2
Conference Proceeding (2) 2
Government Document (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (130) 130
index medicus (109) 109
male (79) 79
female (75) 75
endocrinology & metabolism (60) 60
middle aged (56) 56
oncology (54) 54
adult (52) 52
research (39) 39
aged (38) 38
animals (37) 37
diabetes (26) 26
mice (26) 26
studies (24) 24
laws, regulations and rules (22) 22
risk factors (22) 22
analysis (21) 21
horticulture (20) 20
human resource management (20) 20
health aspects (19) 19
management (18) 18
physiological aspects (17) 17
survival (17) 17
abridged index medicus (16) 16
care and treatment (16) 16
prevalence (16) 16
treatment outcome (16) 16
employers (15) 15
environmental sciences (15) 15
risk (15) 15
pharmacology & pharmacy (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
cancer (13) 13
chemotherapy (13) 13
prognosis (13) 13
united states (13) 13
adolescent (12) 12
biochemistry & molecular biology (12) 12
evaluation (12) 12
mortality (12) 12
nf-e2-related factor 2 - metabolism (12) 12
original reports (12) 12
complications (11) 11
education (11) 11
genetic aspects (11) 11
obesity (11) 11
oxidative stress (11) 11
prospective studies (11) 11
young adult (11) 11
blood glucose - metabolism (10) 10
glucose (10) 10
guidelines (10) 10
methods (10) 10
nf-e2-related factor 2 - genetics (10) 10
pharmacy (10) 10
respiratory system (10) 10
surgery (10) 10
time factors (10) 10
type 2 diabetes (10) 10
water resources (10) 10
aged, 80 and over (9) 9
development and progression (9) 9
digestive system (9) 9
disease (9) 9
employee benefits (9) 9
employment (9) 9
engineering, environmental (9) 9
environment and public health (9) 9
fair labor standards act 1938-us (9) 9
hong kong (9) 9
limnology (9) 9
lung neoplasms - drug therapy (9) 9
survival analysis (9) 9
usage (9) 9
antioxidants (8) 8
behavior (8) 8
child (8) 8
education, scientific disciplines (8) 8
insulin (8) 8
medical research (8) 8
medicine (8) 8
mellitus (8) 8
predictive value of tests (8) 8
quality (8) 8
risk assessment (8) 8
therapy (8) 8
transcription factor nrf2 (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
blood pressure (7) 7
body mass index (7) 7
carcinoma, non-small-cell lung - drug therapy (7) 7
cell line, tumor (7) 7
cells, cultured (7) 7
diagnosis (7) 7
drug therapy (7) 7
gene expression (7) 7
glucose tolerance test (7) 7
immunohistochemistry (7) 7
insulin resistance (7) 7
kelch-like ech-associated protein 1 (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 1/2011, Volume 108, Issue 4, pp. 1433 - 1438
The major obstacle in cancer treatment is the resistance of cancer cells to therapies. Nrf2 is a transcription factor that regulates a cellular defense... 
Cell growth | Chemotherapy | Cell death | Cell lines | HeLa cells | Sensitization | Heterologous transplantation | Tumors | Lung neoplasms | Cancer | Reactive oxygen species | Antioxidant response | Chemosensitization | Natural compounds | CANCER-CELLS | natural compounds | INCREASED EXPRESSION | MULTIDISCIPLINARY SCIENCES | chemosensitization | ANTI-TUMOR AGENTS | KEAP1 | antioxidant response | BRUCEOSIDE-A | LUNG-CANCER | NRF2 | CUL3-BASED E3 LIGASE | reactive oxygen species | SQUAMOUS-CELL CARCINOMAS | SUBSTRATE ADAPTER PROTEIN | Lung Neoplasms - drug therapy | Apoptosis - drug effects | Glutathione - metabolism | Humans | Lung Neoplasms - metabolism | Immunoblotting | Lung Neoplasms - pathology | Antineoplastic Agents - administration & dosage | Cisplatin - administration & dosage | Quassins - pharmacology | Quassins - chemistry | Ubiquitination - drug effects | Antineoplastic Agents - pharmacology | Molecular Structure | Intracellular Space - drug effects | Quassins - administration & dosage | Cisplatin - pharmacology | Drug Synergism | Xenograft Model Antitumor Assays | Animals | Signal Transduction - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mice, Nude | Intracellular Space - metabolism | NF-E2-Related Factor 2 - metabolism | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | HeLa Cells | Physiological aspects | Drug resistance | Patient outcomes | Biological Sciences
Journal Article
Molecular and Cellular Biology, ISSN 0270-7306, 06/2013, Volume 33, Issue 12, pp. 2436 - 2446
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2012, Volume 7, Issue 7, p. e41831
mTOR inhibitors are used clinically to treat renal cancer but are not curative. Here we show that autophagy is a resistance mechanism of human renal cell... 
COMPLEX | TRANSCRIPTION FACTOR NRF2 | MULTIDISCIPLINARY SCIENCES | TARGETING AUTOPHAGY | PROGRAMMED NECROSIS | DEATH MECHANISMS | METABOLIC STRESS | MAMMALIAN-CELLS | CANCER | RENAL-CELL CARCINOMA | MOUSE MODELS | Receptor-Interacting Protein Serine-Threonine Kinases - metabolism | Cell Survival - drug effects | Carcinoma, Renal Cell - pathology | Antioxidants - metabolism | Humans | Mitochondria - metabolism | Basal Metabolism - drug effects | Mitochondria - drug effects | Autophagy - drug effects | Necrosis | TOR Serine-Threonine Kinases - antagonists & inhibitors | Xenograft Model Antitumor Assays | Chloroquine - pharmacology | Animals | Cell Nucleus - metabolism | Active Transport, Cell Nucleus - drug effects | NF-E2-Related Factor 2 - metabolism | Oxidation-Reduction - drug effects | Cell Line, Tumor | Antineoplastic Agents - pharmacology | Mice | Protein Kinase Inhibitors - pharmacology | Cell Nucleus - drug effects | TOR protein | Biotechnology | Oxidative stress | Syngeneic grafts | Genomics | Leukemia | Kinases | Autophagy | Antioxidants | Toxicology | Mitochondria | Cell growth | Allografts | Xenografts | Gangrene | Tumorigenesis | Inhibition | Growth factors | Cytomegalovirus | Cell survival | Bioavailability | Tumor cell lines | Dentistry | Survival | Medicine | Inhibitors | Medical prognosis | Hypoxia | Lymphomas | Mutation | Phagocytosis | Clear cell-type renal cell carcinoma | Kidney transplantation | Cancer | Apoptosis
Journal Article
Journal Article
Journal Article